BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34761681)

  • 1. Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?
    Dhakal P; Wichman CS; Pozehl B; Weaver M; Fisher AL; Vose J; Bociek RG; Bhatt VR
    Future Oncol; 2022 Jan; 18(3):311-321. PubMed ID: 34761681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
    Mühlbacher AC; Nübling M
    Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy.
    Uchida M; Sugie C; Yoshimura M; Suzuki E; Shibamoto Y; Hiraoka M; Akechi T
    Support Care Cancer; 2019 Dec; 27(12):4487-4495. PubMed ID: 30911915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV).
    Rohr I; Alavi S; Richter R; Keller M; Chekerov R; Oskay-Özcelik G; Heinrich M; Taskiran C; Joly F; Berger R; du Bois A; Gornjec A; Vergote I; Achimas-Cadariu P; Lorusso D; Maenpaa J; Sehouli J
    Int J Gynecol Cancer; 2020 Apr; 30(4):509-514. PubMed ID: 32139438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older Adults' Views and Communication Preferences About Cancer Screening Cessation.
    Schoenborn NL; Lee K; Pollack CE; Armacost K; Dy SM; Bridges JFP; Xue QL; Wolff AC; Boyd C
    JAMA Intern Med; 2017 Aug; 177(8):1121-1128. PubMed ID: 28604917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social and clinical determinants of preferences and their achievement at the end of life: prospective cohort study of older adults receiving palliative care in three countries.
    Higginson IJ; Daveson BA; Morrison RS; Yi D; Meier D; Smith M; Ryan K; McQuillan R; Johnston BM; Normand C;
    BMC Geriatr; 2017 Nov; 17(1):271. PubMed ID: 29169346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding health outcome preferences of older adults diagnosed with multiple myeloma.
    Maheshwari S; Arias M; Ubersax C; Tucker A; Bal S; Ravi G; Godby K; Costa LJ; Williams GR; Shrestha S; Bhatia S; Giri S
    J Geriatr Oncol; 2024 Jun; 15(5):101781. PubMed ID: 38714092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preferences for oral versus intravenous palliative chemotherapy.
    Liu G; Franssen E; Fitch MI; Warner E
    J Clin Oncol; 1997 Jan; 15(1):110-5. PubMed ID: 8996131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment.
    Janssen EM; Pollack CE; Boyd C; Bridges JFP; Xue QL; Wolff AC; Schoenborn NL
    Med Decis Making; 2019 Aug; 39(6):621-631. PubMed ID: 31226903
    [No Abstract]   [Full Text] [Related]  

  • 10. A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
    Hamelinck VC; Bastiaannet E; Pieterse AH; de Glas NA; Portielje JE; Merkus JW; den Hoed ID; van de Velde CJ; Liefers GJ; Stiggelbout AM
    Clin Breast Cancer; 2016 Oct; 16(5):379-388. PubMed ID: 27212474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older Adults' Preferences for Discussing Long-Term Life Expectancy: Results From a National Survey.
    Schoenborn NL; Janssen EM; Boyd C; Bridges JFP; Wolff AC; Xue QL; Pollack CE
    Ann Fam Med; 2018 Nov; 16(6):530-537. PubMed ID: 30420368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Stability of Treatment Preferences Among Patients With Advanced Cancer.
    Jabbarian LJ; Maciejewski RC; Maciejewski PK; Rietjens JAC; Korfage IJ; van der Heide A; van Delden JJM; Prigerson HG
    J Pain Symptom Manage; 2019 Jun; 57(6):1071-1079.e1. PubMed ID: 30794935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliciting preferences to inform patient-centred policies: the case of psoriasis.
    Torbica A; Fattore G; Ayala F
    Pharmacoeconomics; 2014 Feb; 32(2):209-23. PubMed ID: 24446282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer.
    Stone RL; Cambron-Mellott MJ; Beusterien K; Maculaitis MC; Ritz S; Mulvihill E; Monberg M; Szamreta EA; Amin S; McLaurin K
    Future Oncol; 2022 Feb; 18(4):491-503. PubMed ID: 34875854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.
    Havrilesky LJ; Scott AL; Davidson BA; Secord AA; Yang JC; Johnson FR; Gonzalez JM; Reed SD
    Gynecol Oncol; 2021 Aug; 162(2):440-446. PubMed ID: 34053748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do some patients prefer to leave decisions up to the doctor: lack of self-efficacy or a matter of trust?
    Chawla N; Arora NK
    J Cancer Surviv; 2013 Dec; 7(4):592-601. PubMed ID: 23892559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of patient autonomy on older adults with asthma.
    Karamched KR; Hao W; Song PX; Carpenter L; Steinberg J; Baptist AP
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):65-68.e1. PubMed ID: 29730013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Hamelinck VC; Bastiaannet E; Pieterse AH; van de Velde CJH; Liefers GJ; Stiggelbout AM
    Clin Breast Cancer; 2018 Apr; 18(2):e245-e253. PubMed ID: 29275105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.
    Teuffel O; Cheng S; Ethier MC; Diorio C; Martino J; Mayo C; Wing R; Sung L; Alibhai SM
    Support Care Cancer; 2012 Nov; 20(11):2755-64. PubMed ID: 22350594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.